Inflammation in Fibromyalgia: New Evidence Changes the Picture
For years, fibromyalgia was considered a condition without measurable inflammation. Two 2026 publications — a broad review in Cells and a systematic meta-analysis in BMC Rheumatology (July 20, 2026) — suggest that picture is incomplete.
What the Meta-Analysis Found
Researchers from Universidad Europea de Madrid pooled data from 18 studies covering 1,605 participants. Across the ten studies with usable data, one biomarker stood out: hsCRP (high-sensitivity C-reactive protein) was significantly elevated in people with fibromyalgia compared to healthy controls. Other markers — hair cortisol, IL-6, and IFN-γ — showed no significant difference.
Inflammation in the Body and the Brain
The broader review adds detail: some patients show low-grade, long-term inflammation that can sensitize nerves to pain, so that normal touch or light activity starts to hurt. Separately, brain-support cells (glia) appear overactive in some patients, worsening pain, fatigue, sleep, and concentration.
The Lifestyle and Gut Connection
Both reviews point to body weight, physical inactivity, diet, and gut bacteria imbalance as factors that may drive this inflammation — a possible reason why not everyone with fibromyalgia has the same symptom pattern.
Why This Matters
This is not a single "fibromyalgia inflammation," and standard anti-inflammatories (NSAIDs) generally don't help much — the mechanism differs from rheumatoid arthritis. But it strengthens the case that fibromyalgia can take different forms, and it supports lifestyle-based approaches (movement, sleep, stress reduction, diet) as genuine parts of a treatment plan, not just "extras."
Note: These findings are population averages from observational studies, not a diagnostic blood test. High hsCRP doesn't confirm fibromyalgia, and normal hsCRP doesn't rule it out.